- 171
- 32 557
Oncology Data Advisor
United States
เข้าร่วมเมื่อ 15 ธ.ค. 2022
Oncology Data Advisor® (OncData) delivers up-to-date, clinically relevant content spanning new drug approvals and cutting-edge scientific breakthroughs, to interviews and commentary from key opinion leaders. Content is carefully tailored to give readers a succinct overview of the latest advances that are directly applicable to their patients and practices.
OncData is the independent, digital resource that provides indispensable information relevant to the multidisciplinary cancer care team. As a leader in medical news and commentary for oncology providers, OncData provides thorough coverage of important clinical research with insightful commentaries that put advances into perspective.
OncData is the independent, digital resource that provides indispensable information relevant to the multidisciplinary cancer care team. As a leader in medical news and commentary for oncology providers, OncData provides thorough coverage of important clinical research with insightful commentaries that put advances into perspective.
Optimizing Sotorasib Dosing in KRAS Lung Cancer: Expert Insights
0:00 Introduction
1:40 Targeted Therapies
8:45 Trial Development
12:00 Precision for Medicine
In this in-depth interview, Matthew Hadfield, DO, speaks with Dr. Harpreet Singh, Chief Medical Officer at Precision for Medicine and former FDA Division Director of Oncology, to explore the critical dosing challenges following the accelerated approval of sotorasib for KRAS-mutated advanced lung cancer. Dr. Singh shares insights from a recent study comparing the FDA-approved 960 mg dose of sotorasib with a lower 240 mg dose, highlighting lessons learned in clinical trial design and regulatory strategies.
Topics discussed include: - The influence of targeted therapies on clinical trial design
- How regulatory bodies adapt to the rapid pace of drug development
- Innovations in trial design, including patient-centered approaches and crossover options
- The role of patient perspectives in dosage decisions and managing toxicities
Gain valuable insights into the future of oncology trials and the evolving standards for therapeutic dosing from a regulatory and patient-focused perspective.
#Sotorasib #KRASLungCancer #Oncology #ClinicalTrials #DrugApproval #PrecisionMedicine #HarpreetSingh #FDA #CancerResearch #LungCancer
1:40 Targeted Therapies
8:45 Trial Development
12:00 Precision for Medicine
In this in-depth interview, Matthew Hadfield, DO, speaks with Dr. Harpreet Singh, Chief Medical Officer at Precision for Medicine and former FDA Division Director of Oncology, to explore the critical dosing challenges following the accelerated approval of sotorasib for KRAS-mutated advanced lung cancer. Dr. Singh shares insights from a recent study comparing the FDA-approved 960 mg dose of sotorasib with a lower 240 mg dose, highlighting lessons learned in clinical trial design and regulatory strategies.
Topics discussed include: - The influence of targeted therapies on clinical trial design
- How regulatory bodies adapt to the rapid pace of drug development
- Innovations in trial design, including patient-centered approaches and crossover options
- The role of patient perspectives in dosage decisions and managing toxicities
Gain valuable insights into the future of oncology trials and the evolving standards for therapeutic dosing from a regulatory and patient-focused perspective.
#Sotorasib #KRASLungCancer #Oncology #ClinicalTrials #DrugApproval #PrecisionMedicine #HarpreetSingh #FDA #CancerResearch #LungCancer
มุมมอง: 25
วีดีโอ
NBCF's Mission: Helping Women Now | Breast Cancer Awareness Month
มุมมอง 1812 ชั่วโมงที่ผ่านมา
0:00 Introduction 2:03 NBCF's Mission 4:05 The Role of Patient Navigators 12:25 Relieving Financial Burden 15:52 NBCF's FAQs 18:25 E-Book for Patients 20:37 National Breast Cancer Retreat 22:20 Awareness 24:45 Metastatic Community 27:12 Promoting Health Equity 32:00 Trust Building and Investment into the Community 34:45 Breast Cancer Education and Action In honor of Breast Cancer Awareness Mont...
Exclusive Sneak Peek: Unlocking What's Next in Genetic Counseling and Cancer Care!
มุมมอง 1116 ชั่วโมงที่ผ่านมา
0:00 Introduction 1:35 Why is Education on Genetic Testing Important? 3:45 Barriers to Integration 6:55 Why Should You Attend? Join us for Pathways to Precision: Integrating Genetic Counseling and Testing Into Cancer Care, a free, live webinar presented by i3 Health. In this exclusive preview, Dr. Filipa Lynce, Director of the Inflammatory Breast Center at Dana-Farber Cancer Center, and Catheri...
National Healthcare Quality Week: Ensuring Safety and Patient-Centered Care
มุมมอง 6119 ชั่วโมงที่ผ่านมา
0:00 Introduction 2:35 University of Rochester Medical Center Quality Institute 7:03 Novel Metrics / Patient Experience 14:50 Patient's Voice 16:30 Takeaways In celebration of National Healthcare Quality Week (October 20-26, 2024), Dr. Lauren Ghazal (University of Rochester) and Dr. Matthew Hadfield (Brown University) discuss the critical importance of ensuring healthcare quality and safety. In...
Fellow of the Month: Jasmin Hundal, MD, MS, MPH | Hematology/Oncology Insights
มุมมอง 3821 ชั่วโมงที่ผ่านมา
0:00 Introduction 0:58 Journey to Becoming a Physician 1:33 Why Heme/Onc Fellowship? 2:10 Research Interests 2:48 Post Fellowship 3:47 Fellowship Experience Learn more about the Fellows Forum and how you can join here! oncfellows.com In this first episode of our Fellow of the Month series, we meet Dr. Jasmin Hundal, a second-year Hematology/Oncology Fellow at the Cleveland Clinic. Dr. Hundal sh...
AI in Pathology: Enhancing Cancer Diagnostics with Dr. Aamir Ehsan
มุมมอง 31วันที่ผ่านมา
In this episode of Exploring Artificial Intelligence in Oncology, Dr. Waqas Haque, MD, sits down with Aamir Ehsan, MD, the Founder and CEO of CorePath Laboratories in San Antonio, Texas. Together they discuss how CorePath utilizes AI in pathology, including the following topics: • Improvements in diagnostic accuracy and efficiency through CorePath's AI diagnostics • CorePath's collaboration wit...
Lobular Breast Cancer Awareness Day: New Studies & Screening Advances
มุมมอง 10714 วันที่ผ่านมา
0:00 Introduction 0:22 Lobular Breast Cancer Awareness Day October 15, 2024, is the inaugural Lobular Breast Cancer Awareness Day! Five states-Texas, Massachusetts, Maryland, Connecticut, and Pennsylvania-have officially declared the day, and ceremonies are happening at MD Anderson and other cancer centers to commemorate this milestone and raise awareness of lobular breast cancer. OncData Edito...
Breakthrough: Inavolisib Combo Wins FDA Nod for Breast Cancer
มุมมอง 7314 วันที่ผ่านมา
0:00 Approval Background 2:30 INAVO120 Trial 4:42 Treatment Landscape 6:12 Mutation Testing 9:10 Side Effects 20:58 Personalized Medicine The FDA has granted approval to inavolisib in combination with palbociclib and fulvestrant for endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative, advanced breast cancer. Just hours after the approval, OncData Editorial Board member Dr. Jason Mou...
World Hospice & Palliative Care Day: Breaking Stigmas & Global Perspectives
มุมมอง 3014 วันที่ผ่านมา
October 12 is World Hospice and Palliative Care Day, a day to raise awareness of the essential services that improve quality of life, offer support, and provide comfort for individuals with life-limiting illnesses. In honor of this day, Fellows Forum members Dr. Nida Khan, a Medical Oncology and Palliative Care Fellow at The Ohio State University, and Dr. Richa Thakur, Palliative Care Physician...
World Mental Health Day: Patient & Provider Insights on Self-Care and Burnout
มุมมอง 2814 วันที่ผ่านมา
0:00 Introduction 0:34 Provider POV 9:01 Patient POV 18:46 Mental Health Statistics 19:50 Therapy 20:58 Final Thoughts In honor of World Mental Health Day on October 10, Oncology Data Advisor Editorial Board members Stephen Freedland, MD and Allison Rosen, MS, sat down to discuss their unique perspectives on mental health as a physician and patient, respectively, featuring the following topics:...
Advances in HNSCC: Immunotherapy & Targeted Treatments for Head and Neck Cancer
มุมมอง 7721 วันที่ผ่านมา
Click here to view the full activity and claim free CME and NCPD credit: bit.ly/3zq79Es 0:00 Introduction 0:57 Advancements for HNSCC 7:25 Toripalimab 8:30 Conclusion Dr. Deborah Wong, Director of the Medical Oncology Program and Clinical Trials Program for Head and Neck Squamous Cell Cancers (HNSCC) and an Associate Clinical Professor of Medicine at the University of California Los Angeles (UC...
Exploring Rare Cancers: Challenges & Innovations
มุมมอง 4728 วันที่ผ่านมา
In this interview, Oncology Data Advisor board members Dr. Matthew Hadfield and Dr. Waqas Haque speak with Dr. Amy O’Sullivan, Dr. Nicholas Robert, and Dr. Zhaohui Su from Ontada, an oncology data science and technology business dedicated to improving the lives of cancer patients through real-world data and evidence generation that accelerates life sciences research. They share insights into th...
Childhood Cancer Awareness Month: A Primer on Pediatric Cancers With Tristan Knight, MD, FRCPC
มุมมอง 36หลายเดือนก่อน
In honor of Childhood Cancer Awareness Month , Oncology Data Advisor's Editorial Board member Dr. Tristan Knight shares his expertise on pediatric cancer. Watch as Dr. Knight discusses: - The history behind Childhood Cancer Awareness Month and the global symbol of the gold ribbon - Key biological differences between pediatric and adult cancers - Common types of pediatric cancers such as leukemi...
World Cancer Research Day: Trends for the Future
มุมมอง 51หลายเดือนก่อน
September 24 is World Cancer Research Day, an annual commemoration of the tireless research being done to reduce the impact of cancer around the globe. In this panel discussion, Oncology Data Advisor board members Allison Rosen, Stephen Freedland, and Waqas Haque share their perspectives on cancer research and advocacy, including: • Current gaps and advances in cancer detection • The rise of mu...
Pain Awareness Month: A Dual Perspective on Navigating Cancer Pain
มุมมอง 35หลายเดือนก่อน
In honor of Pain Awareness Month this September, Oncology Data Advisor Fellows Forum member Richa Thakur, MD, and Editorial Board member Megan-Claire Chase sat down for an enlightening dialogue between clinician and survivor. Dr. Thakur and Ms. Chase bridge the gap and share their respective experiences with treating cancer patients’ pain and what it was like experiencing pain as a cancer survi...
Prostate Cancer Awareness Month: Overcoming Disparities With Waqas Haque, MD, MPH
มุมมอง 51หลายเดือนก่อน
Prostate Cancer Awareness Month: Overcoming Disparities With Waqas Haque, MD, MPH
Blood Cancer Awareness Month: Navigating Hereditary Hematologic Malignancy Genetics
มุมมอง 60หลายเดือนก่อน
Blood Cancer Awareness Month: Navigating Hereditary Hematologic Malignancy Genetics
Lymphoma Awareness Month: Nursing and Patient Advocacy Perspectives
มุมมอง 26หลายเดือนก่อน
Lymphoma Awareness Month: Nursing and Patient Advocacy Perspectives
Take a Loved One to the Doctor Day With Samuel Kareff, MD, MPH, and Matthew Hadfield, DO
มุมมอง 17หลายเดือนก่อน
Take a Loved One to the Doctor Day With Samuel Kareff, MD, MPH, and Matthew Hadfield, DO
Prostate Cancer Awareness Month: The Urologist and Oncologist Perspectives
มุมมอง 38หลายเดือนก่อน
Prostate Cancer Awareness Month: The Urologist and Oncologist Perspectives
Investigating the Impact of Multiple Pharmacy Use and Medication Adherence in Colorectal Cancer
มุมมอง 30หลายเดือนก่อน
Investigating the Impact of Multiple Pharmacy Use and Medication Adherence in Colorectal Cancer
Additional Advances in Immune-Related Adverse Events Research and Trials With Beth Sandy, MSN, CRNP
มุมมอง 68หลายเดือนก่อน
Additional Advances in Immune-Related Adverse Events Research and Trials With Beth Sandy, MSN, CRNP
iCAD: Creating a World Where Cancer Can’t Hide With Waqas Haque, MD, MPH, and Dana Brown
มุมมอง 78หลายเดือนก่อน
iCAD: Creating a World Where Cancer Can’t Hide With Waqas Haque, MD, MPH, and Dana Brown
National Grief Awareness Day: Everyone’s Journey Is Different
มุมมอง 452 หลายเดือนก่อน
National Grief Awareness Day: Everyone’s Journey Is Different
International Overdose Awareness Day: Erasing the Stigma - Alankrita Taneja and Matthew Hadfield
มุมมอง 302 หลายเดือนก่อน
International Overdose Awareness Day: Erasing the Stigma - Alankrita Taneja and Matthew Hadfield
Navigating the Fellowship Application Experience With Jorge Avila, MD
มุมมอง 452 หลายเดือนก่อน
Navigating the Fellowship Application Experience With Jorge Avila, MD
#ActForHumanity: Advocating for Aid Workers on World Humanitarian Day
มุมมอง 252 หลายเดือนก่อน
#ActForHumanity: Advocating for Aid Workers on World Humanitarian Day
World Breast Cancer Research Day: Making Strides in Neuropathy Research
มุมมอง 542 หลายเดือนก่อน
World Breast Cancer Research Day: Making Strides in Neuropathy Research
Summer Sun Safety Month: How to Stay Healthy While Enjoying the Sun
มุมมอง 382 หลายเดือนก่อน
Summer Sun Safety Month: How to Stay Healthy While Enjoying the Sun
The Digital Fingerprint: Accelerating Personalized Drug Discovery and Development at iLoF
มุมมอง 462 หลายเดือนก่อน
The Digital Fingerprint: Accelerating Personalized Drug Discovery and Development at iLoF
I am a cancer patient,i need financial help for my treatment, help me please.
Hi, I visited your TH-cam channel and saw that your channel has many videos and your content is very nice but your channel is not growing well because your channel is not visible to your targeted audience. You need to SEO your channel videos and increase your channel subscribers then your channel will grow and show in front of your targeted audience.
Anything related to phyllodes breast tumor
Dr Banerjee, you mentioned Kaiser s treatment regiment. I d need a little more info about this. New diagnosis MM has Kaiser Sr Plan , is there a way to explore if their protocol is Ideal. Suggestions appreciated.
"We'd recommend talking to your doctor about the details. In brief, Kaiser often uses a drug called isatuximab instead of one called daratumumab. Both work similarly well, but isatuximab is an IV infusion while daratumumab is an injection." - Dr. Banerjee
@@OncData I appreciate that clarification. Thank you
Even the adenocarcinoma if appendix is different from the colonic cancer genomicaly, hence behave differently from the other adeno-ca.
WOW!!! As a Black 8-year invasive lobular breast cancer survivor, I’m thrilled that lobular is finally getting the attention it needs. I look forward to hearing more about this targeted study approach. Is there a way to see his poster online?
@megsie1497 Absolutely! Here is the link for the abstract (1044): meetings.asco.org/meetings/2024-asco-annual-meeting/316/program-guide/search?q=mouabbi
When is GBM agile data coming. thank you
Revlimid is chemotherapy? Or is it that when you say chemo, it applies to transplant eligible procedure?
A cure … very soon… 🙏🏼🙏🏼🙏🏼
What is it that shows up in blood work that gives the indication of mm?
Spike in protein in urine.
Thanks for your reply
Some countries in Europe are more advance in treating Multiple Myeloma in the USA are more interested in making money from patients
Hi I am from Ireland and have been diagnosed with MM in May 2023. Currently after autologus stem cell transplant first month on maintnance therapy with revlimid 15mg.
Indication: Hormone receptor+ve and her2neu -ve breast cancer 1:42
My app was rejected ,so much for helping those in dire need being blk you have to jump thur all sorts of unnecessary hoops I'm too sick for their power tripping bullshit happy for those who did recieve help but pink fund let me down bad for no fuq n reason I was diagnosed with dbl invasive ductual carcinoma, did everything that was asked of me the lady was so damn nasty taking my info I was so taken back especially knowing their reputation I was so let down ,disappointed by the organization, so pink fund can kiss my entire black ass can't let these ppl stress me out any further refuse to beg!!!😢
My father was diagnosed with MM and thankfully he is doing well.. however his hemoglobin levels are low.
"Promosm" 😴
Plz contact me
No one help her she is in danger
Plz one patient have cancer she is much poor and need help
How can u help me
Hi everyone
Iam also suffering from multiple myeloma
Iam also suffering from multiple myeloma ifrom 3 years
In kedwe cancer research centre banglore
Plz answer me
My husband was born in March, diagnosed in March, and lost his battle with MM in March. It’s only right March be called MM Month. ❤️
May your husband rest in peace 🙏🕊️ And may God bless you 🙏
@@emmanuelking9988And what was the cause of he’s death.
I have IgG myeloma:stage III. Paraprotein 79g/L. I started Daratumumab, Velcade, Thalidomide, Dexamethasone. Very soon Velcade and Thalidomide were stopped because of severe peripheral neuropathy. Daratumumab and Dexamethasone reduced my Paraprotein to 0g/L. Daratumumab allowed me to have a bone marrow transplant. I now have Lenalidomide as maintenance therapy.
did he have del17p ? my mom is also on stage 3 taking Dara carzi and dexa
TRY OUT JOE TIPPENS CANCER PROTOCOL FENBENDAZOLE RIGHT AWAY, FENBENDAZOLE REDUCES AND KILLS CANCER CELLS WITH OUT ANY SIDE EFFECTS. AND JESUS LOVES YOU ❤❤
This was wonderful! I'm on Revlimid, Darselex, and Dexamethasone. The therapy has gone well and MDs are happy. I will go to Moffitt in Tampa next week for consult and feel much more confident having seen your video. Thank you for this as I am alone and overwhelmed.
you need support kim, i hope you find it. may GOD be with you on your journey. let me know if i can help.
God bless you. My husband was diagnosed March 8. It was a surprise. I hope you can find some support.
I'm living in Venice and I'm getting staged now - will head to Moffitt or Tampa General for a consultation as well - stay strong :) ❤
Can rfa or mwa could slow down primary and metastis tumor growth
Doesn't generic Abiraterone acetate work just ad well as Enzalutimide, and at a fraction of the cost?!! Or is there a push from big pharma to use Enzalutimide????
Wow, this video was so enlightening! Dr. Christine Ko's expertise in cognitive psychology and emotional intelligence in medicine truly shines through in this interview. It's amazing to see how these aspects can greatly impact patient care and overall well-being. Thank you for sharing this valuable information!
Thank you for sharing your story Will!
Any news on AOH 1996 ?
my brother has been receiving treatment for 2 months, there is no improvement 😢
CAR-T cell therapy often has challenging side effects. The other problem is the total ablation of CD19 and/or CD20 positive cells that are crucial for the development of plasma cells that secrete antibodies necessary for humoral responses. Such individuals must have gamma globulin infusions for the rest of their lives. How about targeting tumor specific neoantigens on tumor cells. I am working on an inexpensive option that does just that.
T2 biology symposium? Ok is this the detector used? Could this be used for blood donors with a blood test?
Hello Hope you are safe and well
I recently visited your TH-cam channel and noticed that it has a visually appealing design, but upon closer examination, I discovered several areas that could use improvement. One crucial aspect is search engine optimisation (SEO), particularly the implementation of rank tags and tag volume. It seems like these elements haven't been fully addressed on your channel. There may be other issues as well, but these are the ones that stood out to me Reply.
Plz contact with me
prove that you are serious - give me my money back
Very nice talk, Sunil!
P R O M O S M 😚
What about nurses that had their ONCC certification expired way over 4 years ago and would like to get back into chemotherapy nursing? Are the requirements different?
@hermosotino Thanks for reaching out! Please find the answer to your question below and let us know if you have any additional questions! Nurses whose ONCC certification has expired after 4 years who would like to retake the certification test would have to meet the eligibility criteria as a lapsed candidate. A lapsed candidate would have to meet the same eligibility criteria as an initial candidate for the credential: www.oncc.org/oncology-certified-nurse-ocn That would be the same for nurses who have let their ONS Chemotherapy certificate expire after 2 years: www.ons.org/courses/onsoncc-chemotherapy-immunotherapy-certificate-course
Thank you for the video